Status:
COMPLETED
Delayed Diagnosis of Multiple Sclerosis, Treatment Initiation and Non-adherence in Upper Egypt
Lead Sponsor:
doaa mokhtar mahmoud
Conditions:
Multiple Sclerosis, Relapsing-Remitting
Eligibility:
All Genders
18-60 years
Brief Summary
The earlier that MS can be diagnosed; the sooner treatment can be initiated with timely reduction of subclinical disease activity and prevention of disability progression. However, significant delays...
Detailed Description
this is cross-sectional study in the Neuropsychiatry department, South Valley university hospitals, where patients with remitting relapsing multiple sclerosis according to McDonald criteria 2017 using...
Eligibility Criteria
Inclusion
- Patient with confirmed diagnosis of remitting relapsing multiple sclerosis according to the 2017 McDonald's criteria and receiving any DMT for at least 3 months.
Exclusion
- Presence of any clinical or radiological finding suggesting a diagnosis other than MS or other demyelinating diseases.
- Presence of other systemic disease or being on long term treatment for any disease.
- Incomplete clinical or radiological data were provided.
- Subject declined to provide written informed consent.
Key Trial Info
Start Date :
June 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2022
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT05438693
Start Date
June 1 2020
End Date
June 1 2022
Last Update
June 30 2022
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
South valley University
Qina, Qena Governorate, Egypt, 83523
2
Assiut University
Asyut, Egypt, 71511